CG vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

CG

50.6
AI Score
VS
FHI Wins

FHI

61.6
AI Score

Investment Advisor Scores

CG

51score
Recommendation
HOLD

FHI

62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CG FHI Winner
Forward P/E 7.6336 9.9206 CG
PEG Ratio 0.6522 1.3978 CG
Revenue Growth -32.9% 18.3% FHI
Earnings Growth -57.5% 19.3% FHI
Tradestie Score 50.6/100 61.6/100 FHI
Profit Margin 13.0% 21.3% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CG 1M: -18.3% · 3M: -3.3% FHI 1M: -11.2% · 3M: +0.5%

Current Technical Phase

CG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 32

RSI (14): 31.6 · Price: $40.03

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.8 · Price: $57.82

Fundamentals Snapshot

Metric CG FHI
Market Cap — —
Forward P/E 7.9 9.8
Trailing P/E 41.5 10.7
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 1.0% 0.7%
Operating Margin 0.3% 0.3%
EPS 0.95 5.37
Dividend Yield 0.04% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.